Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104; Biochemistry and Molecular Biophysics Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
J Biol Chem. 2020 Feb 7;295(6):1517-1538. doi: 10.1074/jbc.RA119.011577. Epub 2019 Dec 27.
Hsp104 is a hexameric AAA ring translocase, which drives protein disaggregation in nonmetazoan eukaryotes. Cryo-EM structures of Hsp104 have suggested potential mechanisms of substrate translocation, but precisely how Hsp104 hexamers disaggregate proteins remains incompletely understood. Here, we employed synchrotron X-ray footprinting to probe the solution-state structures of Hsp104 monomers in the absence of nucleotide and Hsp104 hexamers in the presence of ADP or ATPγS (adenosine 5'--(thiotriphosphate)). Comparing side-chain solvent accessibilities between these three states illuminated aspects of Hsp104 structure and guided design of Hsp104 variants to probe the disaggregase mechanism and We established that Hsp104 hexamers switch from a more-solvated state in ADP to a less-solvated state in ATPγS, consistent with switching from an open spiral to a closed ring visualized by cryo-EM. We pinpointed critical N-terminal domain (NTD), NTD-nucleotide-binding domain 1 (NBD1) linker, NBD1, and middle domain (MD) residues that enable intrinsic disaggregase activity and Hsp70 collaboration. We uncovered NTD residues in the loop between helices A1 and A2 that can be substituted to enhance disaggregase activity. We elucidated a novel potentiated Hsp104 MD variant, Hsp104-RYD, which suppresses α-synuclein, fused in sarcoma (FUS), and TDP-43 toxicity. We disambiguated a secondary pore-loop in NBD1, which collaborates with the NTD and NBD1 tyrosine-bearing pore-loop to drive protein disaggregation. Finally, we defined Leu-601 in NBD2 as crucial for Hsp104 hexamerization. Collectively, our findings unveil new facets of Hsp104 structure and mechanism. They also connect regions undergoing large changes in solvation to functionality, which could have profound implications for protein engineering.
Hsp104 是六聚体 AAA 环移位酶,它在非后生动物真核生物中驱动蛋白质解聚。Hsp104 的冷冻电镜结构提出了底物移位的潜在机制,但 Hsp104 六聚体如何解聚蛋白质仍不完全清楚。在这里,我们使用同步加速器 X 射线足迹法探测 Hsp104 单体在无核苷酸和 Hsp104 六聚体在 ADP 或 ATPγS(腺苷 5'--(硫代三磷酸))存在下的溶液状态结构。将这三种状态之间的侧链溶剂可及性进行比较,揭示了 Hsp104 结构的各个方面,并指导设计 Hsp104 变体以探测解聚酶机制。我们确定 Hsp104 六聚体从 ADP 中的更溶剂化状态转变为 ATPγS 中的较少溶剂化状态,这与冷冻电镜观察到的从开放螺旋到封闭环的转变一致。我们确定了关键的 N 端结构域(NTD)、NTD-核苷酸结合域 1(NBD1)接头、NBD1 和中间结构域(MD)残基,这些残基能够实现内在的解聚酶活性和 Hsp70 协作。我们发现了 A1 和 A2 螺旋之间环上的 NTD 残基,可以取代这些残基以增强解聚酶活性。我们阐明了一种新型增强的 Hsp104 MD 变体 Hsp104-RYD,它可以抑制 α-突触核蛋白、肉瘤融合蛋白(FUS)和 TDP-43 毒性。我们澄清了 NBD1 中的一个辅助孔环,它与 NTD 和 NBD1 酪氨酸孔环协作驱动蛋白质解聚。最后,我们确定 NBD2 中的 Leu-601 对 Hsp104 六聚体化至关重要。总的来说,我们的发现揭示了 Hsp104 结构和机制的新方面。它们还将经历溶剂化变化较大的区域与功能联系起来,这可能对蛋白质工程产生深远影响。